Apathy, executive function, and emotion recognition are the main drivers of functional impairment in behavioral variant of frontotemporal dementia
G Musa Salech, P Lillo, K Van der Hiele… - Frontiers in …, 2022 - frontiersin.org
Background: The cognitive and neuropsychiatric deficits present in patients with behavioral
variant frontotemporal dementia (bvFTD) are associated with loss of functionality in the …
variant frontotemporal dementia (bvFTD) are associated with loss of functionality in the …
A Multidimensional, Person-Centered Framework for Functional Assessment in Dementia: Insights from the 'What','How','To Whom', and 'How Much'Questions
A Slachevsky, F Grandi, D Thumala… - Journal of …, 2024 - content.iospress.com
Dementia is a syndrome characterized by cognitive and neuropsychiatric symptoms
associated with progressive functional decline (FD). FD is a core diagnostic criterion for …
associated with progressive functional decline (FD). FD is a core diagnostic criterion for …
Mild cognitive impairment history and current procedures in low-and middle-income countries: a brief review
L Hartle, H Charchat-Fichman - Dementia & Neuropsychologia, 2021 - SciELO Brasil
Mild cognitive impairment (MCI) is a widely studied concept that has changed over time.
Epidemiology, diagnosis, costs, prognostics, screening procedures, and categorization have …
Epidemiology, diagnosis, costs, prognostics, screening procedures, and categorization have …
[HTML][HTML] The striatum, the hippocampus, and short-term memory binding: Volumetric analysis of the subcortical grey matter's role in mild cognitive impairment
MCV Hernández, R Clark, SH Wang, F Guazzo… - NeuroImage: Clinical, 2020 - Elsevier
Background Deficits in short-term memory (STM) binding are a distinguishing feature of
preclinical stages leading to Alzheimer's disease (AD). However, the neuroanatomical …
preclinical stages leading to Alzheimer's disease (AD). However, the neuroanatomical …
Barriers to effective memory assessments for Alzheimer's disease
MA Parra - Journal of Alzheimer's Disease, 2022 - content.iospress.com
Abstract Recently, Alzheimer's Disease International (ADI) stressed that around 75% of
people living with dementia globally are still not receiving a diagnosis. In this commentary, I …
people living with dementia globally are still not receiving a diagnosis. In this commentary, I …
Safety, tolerability, and efficacy estimate of evoked gamma oscillation in mild to moderate Alzheimer's disease
M Hajós, A Boasso, E Hempel, M Shpokayte… - Frontiers in …, 2024 - frontiersin.org
Background Alzheimer's Disease (AD) is a multifactorial, progressive neurodegenerative
disease that disrupts synaptic and neuronal activity and network oscillations. It is …
disease that disrupts synaptic and neuronal activity and network oscillations. It is …
Insula and amygdala atrophy are associated with functional impairment in subjects with presbycusis
Hearing loss is an important risk factor for dementia. However, the mechanisms that relate
these disorders are still unknown. As a proxy of this relationship, we studied the structural …
these disorders are still unknown. As a proxy of this relationship, we studied the structural …
Predictors of functional impairment and awareness in people with dementia, mild cognitive impairment and healthy older adults from a middle-income country
L Hartle, DC Mograbi, HC Fichman, CA Faria… - Frontiers in …, 2022 - frontiersin.org
Objective To investigate the demographic, clinical and cognitive correlates of functional
capacity and its awareness in people with dementia (PwD; n= 104), mild cognitive …
capacity and its awareness in people with dementia (PwD; n= 104), mild cognitive …
The “when” matters: Evidence from memory markers in the clinical continuum of Alzheimer's disease.
Objective: Cognitive assessment able to detect impairments in the early neuropathological
stages of Alzheimer's disease (AD) is urgently needed. The visual short-term memory …
stages of Alzheimer's disease (AD) is urgently needed. The visual short-term memory …
Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1, 4‐dione derivatives as anti‐Alzheimer's agents
The development of targeted phthalazine‐1, 4‐dione acetylcholinesterase (AChE) inhibitors
for treating Alzheimer's disease involved the synthesis of 32 compounds via a multistage …
for treating Alzheimer's disease involved the synthesis of 32 compounds via a multistage …